Investor profile
SV Life Sciences has backed 4 European tech companies across 4 funding rounds between 2011 and 2017, joining rounds totalling €95M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Artios | UK | 1 | €29M |
| Pulmocide | UK | 1 | €28M |
| Kesios Therapeutics | UK | 1 | €27M |
| Imperial Innovations Limited | UK | 1 | €11M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Artios | Series A | €29M | 2016-09 |
| Pulmocide | Series B | €28M | 2017-03 |
| Kesios Therapeutics | Series A | €27M | 2015-12 |
| Imperial Innovations Limited |
| Other |
| €11M |
| 2011-12 |
